Abstract
This systematic review and meta-analysis of cardiovascular outcome trials examines the effects of GLP-1RA in the treatment of patients with type 2 diabetes.
Topics:
Citation
Kristensen SL et al. Lancet Diabetes Endocrinol 2019;7(10):776-785.
